Health

Emerging clinical trial data demonstrates unprecedented cardiovascular and neuroprotective benefits of dual and triple incretin receptor agonists, transforming pharmacological approaches to chronic inflammation and metabolic disease.

Deep learning models analyzing whole-slide images identify subtle spatial biomarkers and tumor-infiltrating lymphocyte patterns that predict immunotherapy responsiveness with greater accuracy than standard immunohistochemistry.